Feed ATRA
AT
Atara Biotherapeutics, Inc.
ATRA · NASDAQ
$8.63 +3.11% (+$0.26)
1M -20.92%
Market Cap $77.8M
P/E Ratio -
Div. Yield -
ROE 25.68%
Bulios Fair Price
$170.86
1879.8% upside
Aktuální cena
$8.63
Podhodnoceno Férová hodnota Nadhodnoceno
Valuation
26 /100
Expensive P/S 3.44x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 23.85%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 96.04%
Net margin 0.00%
FCF margin 0.00%
Quality
38 /100
Average ROIC 0.00%
ROE 25.68%
Asset turnover 1.13x
Debt
71 /100
Low Current ratio 2.16x
Int. coverage -0.00x
Net debt/EBITDA -0.20x
Stability
3 /100
Unstable Beta 0.09x
Rev. volatility 838.38%
Profitable years 1
Zeptejte se StockBota na ATRA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Anhco Nguyen
Employees
14
Headquarters
Thousand Oaks
Nadcházející události
10 SRP
Earnings
Upcoming earnings report